Coagulation labs are blood tests that measure how well, and how quickly, your blood forms a clot. The core panel is the prothrombin time (PT/INR), the activated partial thromboplastin time (aPTT), fibrinogen, and a platelet count. Specialized tests such as mixing studies, factor assays, and D-dimer follow if needed. Together they help diagnose coagulation disorders, monitor blood thinners, check liver function, and assess bleeding risk before surgery.
In this guide I walk through each test, its usual reference range, what an abnormal result points to, and the pitfalls that catch out even experienced clinicians.
How the Coagulation Cascade Maps to the Tests
Clotting is a chain of enzyme reactions in which each clotting factor activates the next. The end result is thrombin, which converts fibrinogen into a fibrin mesh that holds a platelet plug in place. For a fuller walk-through, see our article on the blood coagulation process.
Labs still use the classic test-tube model because it lines up neatly with the tests:
- Extrinsic pathway (factor VII) is measured by the PT.
- Intrinsic pathway (factors XII, XI, IX, VIII) is measured by the aPTT.
- Common pathway (factors X, V, II, and fibrinogen) affects both PT and aPTT.
- Final step, fibrinogen to fibrin, is measured by the thrombin time.
In the body, the pathways are tightly linked and run on cell surfaces rather than as separate chains. The model still works well for sorting out an abnormal result.
The Core Coagulation Panel and Normal Ranges
Reference ranges vary between laboratories and reagents, so always read a result against the range printed on the report. Typical adult values are shown below.
| Test | Typical reference range | What it mainly assesses |
|---|---|---|
| Prothrombin time (PT) | About 11–13.5 seconds | Factor VII plus common pathway; warfarin, liver, vitamin K |
| INR | About 0.8–1.1 (target 2.0–3.0 on warfarin for most indications) | Standardized PT for comparing between labs |
| aPTT | About 25–35 seconds | Factors XII, XI, IX, VIII plus common pathway; unfractionated heparin |
| Thrombin time (TT) | About 14–19 seconds | Fibrinogen quantity and function; heparin or dabigatran effect |
| Fibrinogen | About 200–400 mg/dL (2–4 g/L) | Clot substrate; low in DIC, liver failure, massive bleeding |
| Platelet count | 150–450 × 10⁹/L | Number of platelets, not their function |
| D-dimer | Below about 0.5 µg/mL FEU | Fibrin breakdown; helps rule out clots when negative |
A normal PT and aPTT do not exclude a bleeding problem. Von Willebrand disease, platelet function defects, factor XIII deficiency, and vascular disorders can all present with normal screening tests. That is why the clinical history matters so much.
Interpreting Abnormal Coagulation Labs
The pattern of results narrows the possible causes quickly.
| PT | aPTT | Common causes |
|---|---|---|
| Prolonged | Normal | Warfarin, vitamin K deficiency, early liver disease, factor VII deficiency |
| Normal | Prolonged | Heparin, hemophilia A or B, factor XI or XII deficiency, lupus anticoagulant, some von Willebrand disease |
| Prolonged | Prolonged | Advanced liver disease, DIC, severe vitamin K deficiency, common-pathway factor deficiency, very low fibrinogen, direct oral anticoagulants |
| Normal | Normal | Platelet disorders, von Willebrand disease, factor XIII deficiency, vascular causes |
A mixing study is the next step for an unexplained prolonged time. Patient plasma is mixed 1:1 with normal plasma. If the time corrects, a factor is missing. If it stays prolonged, an inhibitor is present, such as a lupus anticoagulant or an acquired factor VIII antibody. Specific factor assays then name the deficient factor.
Deficiencies found this way sit within a wider range of bleeding disorders. Tests for clotting tendency, such as antithrombin, protein C and S, factor V Leiden, and antiphospholipid antibodies, belong to the thrombophilia workup for blood clotting disorders.
Common Causes of Abnormal Results
Liver disease
The liver makes most clotting factors, so the PT/INR is one of the best measures of liver synthetic function. In chronic liver disease the body also makes fewer natural anticoagulants. A high INR here does not reliably predict bleeding, and these patients can still develop clots.
Vitamin K deficiency
Factors II, VII, IX, and X need vitamin K to work. Poor diet, malabsorption, prolonged antibiotics, and warfarin all lower their activity. Factor VII has the shortest half-life, so the PT rises first.
Medications
Warfarin raises the INR, and unfractionated heparin raises the aPTT. Direct oral anticoagulants such as rivaroxaban, apixaban, and dabigatran affect the tests unpredictably. Drug-specific assays such as calibrated anti-Xa levels or a dilute thrombin time are better for measuring them.
Consumptive and systemic conditions
In disseminated intravascular coagulation (DIC), sepsis, trauma, cancer, or obstetric emergencies use up factors and platelets. The result is prolonged PT and aPTT, low fibrinogen, low platelets, and a high D-dimer. These patterns come up often across hematologic disorders and blood coagulation disorders more broadly.
Pre-Analytical Pitfalls That Cause False Results
In my experience, a surprising share of “abnormal” coagulation labs are sample problems rather than disease. Before chasing a result, check the following:
- Underfilled tube: the light-blue citrate tube needs a 9:1 blood-to-anticoagulant ratio. Too little blood leaves too much citrate, which falsely prolongs clotting times.
- High hematocrit: in polycythemia there is less plasma for the same amount of citrate, which also prolongs times. The lab can adjust the citrate volume.
- Heparin contamination: blood drawn through a heparinized line can give a very prolonged aPTT and TT.
- Clotted or hemolyzed samples: these use up factors and give unreliable results.
- Processing delay: labile factors, especially factor VIII, decay if the sample sits too long.
When a result does not fit the clinical picture, a careful repeat draw is often the most useful next test.
Beyond the Screening Panel
Several further tests answer questions the PT and aPTT cannot:
- Platelet function testing for suspected platelet defects or antiplatelet drug effect. See our overview of platelet function.
- Von Willebrand panel: VWF antigen, VWF activity, and factor VIII.
- Anti-Xa assay for monitoring low molecular weight heparin, or unfractionated heparin when the aPTT is unreliable.
- Viscoelastic testing (TEG or ROTEM), a whole-blood test used at the bedside in trauma, cardiac surgery, and liver transplantation to guide transfusion in real time.
For more on how these tests fit together, our blood clotting guide links out to each condition.
Key Takeaways
- PT/INR tests the extrinsic and common pathways, and aPTT the intrinsic and common pathways. The pattern points to the cause.
- Mixing studies separate factor deficiency from an inhibitor.
- Normal screening tests do not rule out von Willebrand disease or platelet disorders.
- Always rule out sample problems before acting on an unexpected result.
- Direct oral anticoagulants need drug-specific assays, not routine clotting times.
Frequently Asked Questions
Do I need to fast before coagulation labs?
Usually not. Fasting is not needed for PT, aPTT, or fibrinogen, although your doctor may ask you to fast if other tests are drawn at the same time. Tell the lab about any blood thinners, and when you took your last dose.
What is the difference between PT and INR?
The PT is the raw clotting time in seconds, which differs between laboratories and reagents. The INR converts it into a standard ratio so warfarin results can be compared anywhere. For most warfarin indications the target INR is 2.0–3.0.
Can a high INR occur without taking warfarin?
Yes. Liver disease, vitamin K deficiency, some antibiotics, DIC, and rare inherited factor deficiencies can all raise the INR. An unexplained high INR should always be investigated.
Why is my aPTT prolonged but I have never bled?
Factor XII deficiency and lupus anticoagulant both prolong the aPTT without causing bleeding. Lupus anticoagulant is in fact linked to clotting. A mixing study and specific tests will tell them apart.
